Evidence map›Paper›PMID 23716049›Full record

ArticleAntimicrobial agents and chemotherapy2013

Two multidrug-resistant clinical isolates of Bacteroides fragilis carry a novel metronidazole resistance nim gene (nimJ).

Fasahath Husain, Yaligara Veeranagouda, Justin Hsi, Rosemary Meggersee, Valerie Abratt, Hannah M Wexler

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Antibiotic Resistance and Mechanisms of Pathogenic Bacteria in Tubo-Ovarian Abscess.Frontiers in cellular and infection microbiology · 2022
    Review
  5. Characterization of Metronidazole-ResistantFrontiers in microbiology · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. A study on Nim expression in Bacteroides fragilis.Microbiology (Reading, England) · 2014
    Article
  17. Article
  18. Antimicrobial Resistance Profile andJournal of global infectious diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fasahath HusainGLAVAHCS, Los Angeles, California, USA. fhusain99@yahoo.com
Yaligara Veeranagouda
Justin Hsi
Rosemary Meggersee
Valerie Abratt
Hannah M Wexler
University of California, Los Angeles · USUniversity of Cape Town · ZA

Funding

Metronidazole resistance in Bacteroides fragilis: an integrated approachR21AI109545 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI WEXLER, HANNAH · 2014 to 2015
$338k
Regulation of Bacteroides fragilis multidrug efflux pumpsR56AI083649 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI WEXLER, HANNAH · 2010 to 2010
$318k
NIAID NIH HHS 1R56AI083649-01A2NIAID NIH HHS R21 AI109545NIAID NIH HHS R56 AI083649
6 · The paper itself

Abstract

Two multidrug-resistant Bacteroides fragilis clinical isolates contain and express a novel nim gene, nimJ, that is not recognized by the "universal" nim primers and can confer increased resistance to metronidazole when introduced into a susceptible strain on a multicopy plasmid. HMW615, an appendiceal isolate, contains at least two copies of nimJ on its genome, while HMW616, an isolate from a patient with sepsis, contains one genomic copy of nimJ. B. fragilis NimJ is phylogenetically closer to Prevotella baroniae NimI and Clostridium botulinum NimA than to the other known Bacteroides Nim proteins. The predicted protein structure of NimJ, based on fold recognition analysis, is consistent with the crystal structures derived for known Nim proteins, and specific amino acid residues important for substrate binding in the active site are conserved. This study demonstrates that the "universal" nim primers will not detect all nim genes with the ability to confer metronidazole resistance, but nimJ alone cannot account for the very high metronidazole MICs of these resistant clinical isolates.

Indexed as

Genes, BacterialAnti-Bacterial AgentsBacteroides fragilisCatalytic DomainCloning, MolecularDNA PrimersDrug Resistance, Multiple, BacterialMetronidazoleMicrobial Sensitivity TestsPhylogenyPlasmidsProtein FoldingTranscription, GeneticAnti-Bacterial AgentsDNA PrimersMetronidazole

Identifiers

PMID23716049
PMCPMC3719759
OpenAlexW2125315144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.